In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE Drug Master File in Korea (PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE. The MFDS reviews the PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE KDMF as part of the drug registration process and uses the information provided in the PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE KDMF to evaluate the safety and efficacy of the drug.
After submitting a PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE suppliers with KDMF on PharmaCompass.